Dayondon, Mary Grace P.
HRN: 25-20-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2026
01/11/2026
IV
500mg
Q8h
S/P CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes